INVA vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

INVA

42.0
AI Score
VS
INVA Wins

ZYME

33.4
AI Score

Investment Advisor Scores

INVA

42score
Recommendation
HOLD

ZYME

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric INVA ZYME Winner
Forward P/E 8.5616 20.2429 INVA
PEG Ratio 2.855 0 Tie
Revenue Growth -1.6% -90.6% INVA
Earnings Growth 590.4% 0.0% INVA
Tradestie Score 42.0/100 33.4/100 INVA
Profit Margin 44.1% 0.0% INVA
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

INVA 1M: -9.5% · 3M: -10.5% ZYME 1M: +6.9% · 3M: +5.4%

Current Technical Phase

INVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $18.97

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $26.47

Fundamentals Snapshot

Metric INVA ZYME
Market Cap — —
Forward P/E 8.8 23.9
Trailing P/E 8.1 54.8
Revenue (TTM) — —
Revenue Growth 0.0% 8.3%
Gross Margin 0.8% 0.5%
Operating Margin 0.4% 0.2%
EPS 2.32 0.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.